Biogen’s Tecfidera Survives PTAB Challenge

March 27, 2017

U.S. Patent No. 8,399,514

C&ENews Article Link:

http://cen.acs.org/articles/95/i13/Biogens-patent-Tecfidera-upheld.html?type=paidArticleContent

The USPTO Patent Trial and Appeal Board (PTAB) previously (September 2, 2015) denied institution of another Inter Partes Review brought by the Coalition for Affordable Drugs, et al. against U.S. 8,399,514.